Cargando…
TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21
TWEAK is a member of the TNF superfamily of cytokines that contribute to kidney tubulointerstitial injury. It has previously been reported that TWEAK induces transient nuclear translocation of RelA and expression of RelA-dependent cytokines in renal tubular cells. Additionally, TWEAK induced long-la...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813291/ https://www.ncbi.nlm.nih.gov/pubmed/20126461 http://dx.doi.org/10.1371/journal.pone.0008955 |
_version_ | 1782176909846642688 |
---|---|
author | Sanz, Ana B. Sanchez-Niño, Maria D. Izquierdo, Maria C. Jakubowski, Aniela Justo, Pilar Blanco-Colio, Luis M. Ruiz-Ortega, Marta Selgas, Rafael Egido, Jesús Ortiz, Alberto |
author_facet | Sanz, Ana B. Sanchez-Niño, Maria D. Izquierdo, Maria C. Jakubowski, Aniela Justo, Pilar Blanco-Colio, Luis M. Ruiz-Ortega, Marta Selgas, Rafael Egido, Jesús Ortiz, Alberto |
author_sort | Sanz, Ana B. |
collection | PubMed |
description | TWEAK is a member of the TNF superfamily of cytokines that contribute to kidney tubulointerstitial injury. It has previously been reported that TWEAK induces transient nuclear translocation of RelA and expression of RelA-dependent cytokines in renal tubular cells. Additionally, TWEAK induced long-lasting NFκB activation suggestive of engagement of the non-canonical NFκB pathway. We now explore TWEAK-induced activation of NFκB2 and RelB, as well as expression of CCL21, a T-cell chemotactic factor, in cultured murine tubular epithelial cells and in healthy kidneys in vivo. In cultured tubular cells, TWEAK and TNFα activated different DNA-binding NFκB complexes. TWEAK-induced sustained NFκB activation was associated with NFκB2 p100 processing to p52 via proteasome and nuclear translocation and DNA-binding of p52 and RelB. TWEAK, but not TNFα used as control), induced a delayed increase in CCL21a mRNA (3.5±1.22-fold over control) and CCL21 protein (2.5±0.8-fold over control), which was prevented by inhibition of the proteasome, or siRNA targeting of NIK or RelB, but not by RelA inhibition with parthenolide. A second NFκB2-dependent chemokine, CCL19, was upregulates by TWEAK, but not by TNFα. However, both cytokines promoted chemokine RANTES expression (3-fold mRNA at 24 h). In vivo, TWEAK induced nuclear NFκB2 and RelB translocation and CCL21a mRNA (1.5±0.3-fold over control) and CCL21 protein (1.6±0.5-fold over control) expression in normal kidney. Increased tubular nuclear RelB and tubular CCL21 expression in acute kidney injury were decreased by neutralization (2±0.9 vs 1.3±0.6-fold over healthy control) or deficiency of TWEAK (2±0.9 vs 0.8±0.6-fold over healthy control). Moreover, anti-TWEAK treatment prevented the recruitment of T cells to the kidney in this model (4.1±1.4 vs 1.8±1-fold over healthy control). Our results thus identify TWEAK as a regulator of non-canonical NFκB activation and CCL21 expression in tubular cells thus promoting lymphocyte recruitment to the kidney during acute injury. |
format | Text |
id | pubmed-2813291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-28132912010-02-03 TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 Sanz, Ana B. Sanchez-Niño, Maria D. Izquierdo, Maria C. Jakubowski, Aniela Justo, Pilar Blanco-Colio, Luis M. Ruiz-Ortega, Marta Selgas, Rafael Egido, Jesús Ortiz, Alberto PLoS One Research Article TWEAK is a member of the TNF superfamily of cytokines that contribute to kidney tubulointerstitial injury. It has previously been reported that TWEAK induces transient nuclear translocation of RelA and expression of RelA-dependent cytokines in renal tubular cells. Additionally, TWEAK induced long-lasting NFκB activation suggestive of engagement of the non-canonical NFκB pathway. We now explore TWEAK-induced activation of NFκB2 and RelB, as well as expression of CCL21, a T-cell chemotactic factor, in cultured murine tubular epithelial cells and in healthy kidneys in vivo. In cultured tubular cells, TWEAK and TNFα activated different DNA-binding NFκB complexes. TWEAK-induced sustained NFκB activation was associated with NFκB2 p100 processing to p52 via proteasome and nuclear translocation and DNA-binding of p52 and RelB. TWEAK, but not TNFα used as control), induced a delayed increase in CCL21a mRNA (3.5±1.22-fold over control) and CCL21 protein (2.5±0.8-fold over control), which was prevented by inhibition of the proteasome, or siRNA targeting of NIK or RelB, but not by RelA inhibition with parthenolide. A second NFκB2-dependent chemokine, CCL19, was upregulates by TWEAK, but not by TNFα. However, both cytokines promoted chemokine RANTES expression (3-fold mRNA at 24 h). In vivo, TWEAK induced nuclear NFκB2 and RelB translocation and CCL21a mRNA (1.5±0.3-fold over control) and CCL21 protein (1.6±0.5-fold over control) expression in normal kidney. Increased tubular nuclear RelB and tubular CCL21 expression in acute kidney injury were decreased by neutralization (2±0.9 vs 1.3±0.6-fold over healthy control) or deficiency of TWEAK (2±0.9 vs 0.8±0.6-fold over healthy control). Moreover, anti-TWEAK treatment prevented the recruitment of T cells to the kidney in this model (4.1±1.4 vs 1.8±1-fold over healthy control). Our results thus identify TWEAK as a regulator of non-canonical NFκB activation and CCL21 expression in tubular cells thus promoting lymphocyte recruitment to the kidney during acute injury. Public Library of Science 2010-01-29 /pmc/articles/PMC2813291/ /pubmed/20126461 http://dx.doi.org/10.1371/journal.pone.0008955 Text en Sanz et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Sanz, Ana B. Sanchez-Niño, Maria D. Izquierdo, Maria C. Jakubowski, Aniela Justo, Pilar Blanco-Colio, Luis M. Ruiz-Ortega, Marta Selgas, Rafael Egido, Jesús Ortiz, Alberto TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 |
title | TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 |
title_full | TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 |
title_fullStr | TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 |
title_full_unstemmed | TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 |
title_short | TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 |
title_sort | tweak activates the non-canonical nfκb pathway in murine renal tubular cells: modulation of ccl21 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813291/ https://www.ncbi.nlm.nih.gov/pubmed/20126461 http://dx.doi.org/10.1371/journal.pone.0008955 |
work_keys_str_mv | AT sanzanab tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT sanchezninomariad tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT izquierdomariac tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT jakubowskianiela tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT justopilar tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT blancocolioluism tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT ruizortegamarta tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT selgasrafael tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT egidojesus tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 AT ortizalberto tweakactivatesthenoncanonicalnfkbpathwayinmurinerenaltubularcellsmodulationofccl21 |